Description

This research service analyzes the market for the preimplantation genetic diagnosis (PGD) market. Key market drivers and restraints are ranked and discussed. PGD revenue forecasts are modeled largely on annual IVF cycles plus adoption patterns and are validated. A market share analysis by annual PGD volume and a product analysis by chromosomal or gene level detection is also provided. The competitive structure is provided for suppliers of PGD services. The major market challenges are outlined along with strategic recommendations to address them. The key service providers discussed include Reprogenetics, LabCorp, Genesis Genetics Institute, Reproductive Genetics Institute, and other laboratories that provide PGD services.